NCT02623673View on ClinicalTrials.gov

Simultaneous Therapy With Intravitreal Dexamethasone Implant and Bevacizumab for the Treatment of Macular Edema

CompletedOBSERVATIONAL
Enrollment

20

Participants

Timeline

Start Date

September 30, 2015

Primary Completion Date

December 31, 2015

Study Completion Date

February 29, 2016

Conditions
Macular Edema
Interventions
DRUG

simultaneous treatment with intravitreal injection of bevacizumab 1.25mg and intravitreal implant of dexamethasone 0.7mg.

Trial Locations (1)

06010-130

Retina Clinic / UNIFESP, São Paulo

All Listed Sponsors
lead

Retina Clinic, Sao Paulo, Brazil

OTHER

NCT02623673 - Simultaneous Therapy With Intravitreal Dexamethasone Implant and Bevacizumab for the Treatment of Macular Edema | Biotech Hunter | Biotech Hunter